Last reviewed · How we verify
Pedyphar Ointment
Pedyphar Ointment is a topical formulation designed to treat pedal (foot) conditions through local application of active pharmaceutical ingredients.
Pedyphar Ointment is a topical formulation designed to treat pedal (foot) conditions through local application of active pharmaceutical ingredients. Used for Pedal dermatological conditions (specific indication not publicly detailed).
At a glance
| Generic name | Pedyphar Ointment |
|---|---|
| Sponsor | European Egyptian Pharmaceutical Industries |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
As a topical ointment, Pedyphar delivers therapeutic agents directly to affected foot tissues, avoiding systemic absorption and minimizing systemic side effects. The specific active ingredients and their precise mechanism are not publicly detailed in available literature, limiting mechanistic characterization.
Approved indications
- Pedal dermatological conditions (specific indication not publicly detailed)
Common side effects
Key clinical trials
- Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment (PHASE3)
- Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pedyphar Ointment CI brief — competitive landscape report
- Pedyphar Ointment updates RSS · CI watch RSS
- European Egyptian Pharmaceutical Industries portfolio CI